Pierre Branger

Caen, 14000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.

Journal: Neurology

Published: April 01, 2026

Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: JAMA neurology

Published: March 23, 2026

Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.

Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.

Journal: BMC neurology

Published: July 22, 2025

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Journal: Revue neurologique

Published: April 22, 2025

Can a virtual reality tool detect minor executive functions impairment in patients with multiple sclerosis?

Can a virtual reality tool detect minor executive functions impairment in patients with multiple sclerosis?

Journal: Revue neurologique

Published: March 24, 2025

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.

Journal: Neurology

Published: July 11, 2024

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.

Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 15, 2024

Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.

Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 12, 2024

COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.

COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 22, 2024

Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies.

Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies.

Journal: Journal of neuroimmunology

Published: January 18, 2024

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 22, 2023

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.

Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 11, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026